Spaulding Clinical to Disrupt Cardiac Safety Industry with Latest Innovation at DIA 2016

Top Quote Wireless, hand-held electrocardiograph designed to simplify the collection and transmission of ECG data for Pharmaceutical Sponsors to be exhibited at the Drug Information Association's (DIA) 2016 conference. End Quote
  • (1888PressRelease) June 24, 2016 - West Bend, Wisconsin, USA - Spaulding Clinical Research, LLC, a global clinical pharmacology, cardiac safety and biometrics solutions provider, today announced that the Spaulding Electrocardiograph 2100iQ™ is to be exhibited at the Drug Information Association's (DIA) 2016 conference.

    The Spaulding 12-Lead ECG product line was originally launched in 2011 and is now in use in over 35 countries. The Spaulding Electrocardiograph 2100iQ has been optimized to visualize collected real-time digital ECG data via Bluetooth® using iOS™ 7+, Android™ 4.2+ and Windows™ 7+ devices. Data is wirelessly uploaded to the Spaulding webECG™ management cloud for Cardiologist over-reads and is designed to integrate with electronic medical records and clinical information management systems.

    Small (3.5 in), Lightweight (3.3 oz) Design for Easy Storage and Reduced Shipping Costs
    Single Button Operation for Ease of Use
    Protocol-Driven User Interface
    Multiple Protocol Support to Eliminate Need of Additional Equipment
    Stores up to 5 minutes of ECG data, Eliminates Need for Triplicate ECGs

    "The Spaulding Electrocardiograph 2100iQ makes it logistically and financially feasible to collect very high-quality, centralized ECG data," said Dr. Jay Mason, Chief Medical Officer. "This innovation in cardiac safety sets a new standard for data collection and gives Pharmaceutical Sponsors the ability to make earlier and better-informed drug development decisions."

    About Spaulding Clinical Research, LLC
    Spaulding Clinical Research, LLC is a global CRO providing Phase I - IV drug development services to the biotechnology and pharmaceutical industries. Spaulding Clinical Research operates a 200-bed Clinical Pharmacology Unit, Cardiac Core Laboratory and provides full Biometrics/Scientific Affairs services.

  • FB Icon Twitter Icon In-Icon
Contact Information